Language

Medicine shortages: Czechia · Page 14

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

970 notices · Page 14 / 20

← Europe overview

National authority sources: Czechia

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Czechia · Page 14

Czechia

SERTIVAN 50MG TBL FLM 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SERTRALIN

Notice details →
Czechia

SERTIVAN 50MG TBL FLM 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SERTRALIN

Notice details →
Czechia

SIRDALUD 2MG TBL NOB 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: TIZANIDIN

Notice details →
Czechia

SOTAHEXAL 160MG TBL NOB 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SOTALOL

Notice details →
Czechia

SUMATRIPTAN VIATRIS 100MG TBL FLM 2

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SUMATRIPTAN

Notice details →
Czechia

TAXIMED 1G INJ/INF PLV SOL 10

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: CEFOTAXIM

Notice details →
Czechia

VALTREX 500MG TBL FLM 42

Marketing resumed · Not specified
Active ingredient: VALACIKLOVIR

Notice details →
Czechia

VILDAGLIPTIN SANDOZ 50MG TBL NOB 56

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: VILDAGLIPTIN

Notice details →
Czechia

ZABCARE 10MG TBL FLM 90

Marketing resumed · Not specified
Active ingredient: SOLIFENACIN

Notice details →
Czechia

ZABCARE 5MG TBL FLM 90

Marketing resumed · Not specified
Active ingredient: SOLIFENACIN

Notice details →
Czechia

BONDULC 40MCG/ML OPH GTT SOL 3X2,5ML

Marketing resumed · Not specified
Active ingredient: TRAVOPROST

Notice details →
Czechia

CLARITHROMYCIN TEVA 250MG TBL FLM 14 II

Marketing resumed · Not specified
Active ingredient: KLARITHROMYCIN

Notice details →
Czechia

CLARITHROMYCIN TEVA 500MG TBL FLM 14 II

Marketing resumed · Not specified
Active ingredient: KLARITHROMYCIN

Notice details →
Czechia

DIPEPTIVEN 200MG/ML INF CNC SOL 10X100ML

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons; according to SÚKL, no substitute is available
Active ingredient: ALANYLGLUTAMIN

Notice details →
Czechia

ELICEA 10MG TBL FLM 30

Marketing resumed · Not specified
Active ingredient: ESCITALOPRAM

Notice details →
Czechia

ELOCTA 750IU INJ PSO LQF 1+1X3ML ISP+AD

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: KOAGULAČNÍ FAKTOR VIII

Notice details →
Czechia

INDAP 2,5MG CPS DUR 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: INDAPAMID

Notice details →
Czechia

LADUROT 0,5MG/0,4MG CPS DUR 90

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: TAMSULOSIN A DUTASTERID

Notice details →
Czechia

LERPIN 20MG TBL FLM 98

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: LERKANIDIPIN

Notice details →
Czechia

MARIXINO 20MG TBL FLM 28

Marketing resumed · Not specified
Active ingredient: MEMANTIN

Notice details →
Czechia

PERINPA 8MG/2,5MG TBL NOB 30

Marketing resumed · Not specified
Active ingredient: PERINDOPRIL A DIURETIKA

Notice details →
Czechia

RAMIPRIL ACTAVIS 10MG TBL NOB 90

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RAMIPRIL

Notice details →
Czechia

RAMIPRIL ACTAVIS 2,5MG TBL NOB 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RAMIPRIL

Notice details →
Czechia

RAMIPRIL ACTAVIS 2,5MG TBL NOB 50

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RAMIPRIL

Notice details →
Czechia

RAMIPRIL ACTAVIS 5MG TBL NOB 90

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RAMIPRIL

Notice details →
Czechia

TOBRADEX 3MG/G+1MG/G OPH UNG 3,5G

Marketing resumed · Not specified
Active ingredient: DEXAMETHASON A ANTIINFEKTIVA

Notice details →
Czechia

TOLUCOMBI 80MG/25MG TBL NOB 30X1 II

Marketing resumed · Not specified
Active ingredient: TELMISARTAN A DIURETIKA

Notice details →
Czechia

ZYNYZ 500MG INF CNC SOL 1X20ML

Marketing resumed · Not specified
Active ingredient: RETIFANLIMAB

Notice details →
Czechia

ROCALTROL 0,25MCG CPS MOL 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KALCITRIOL

Notice details →
Czechia

AGEN 10MG TBL NOB 100 II

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: AMLODIPIN

Notice details →
Czechia

ANTITHROMBIN III BAXALTA 50IU/ML INF PSO LQF 1+1X20ML

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: ANTITROMBIN III

Notice details →
Czechia

ATOMINEX 10MG CPS DUR 7 I

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ATOMOXETIN

Notice details →
Czechia

ATOMINEX 60MG CPS DUR 28 I

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ATOMOXETIN

Notice details →
Czechia

CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X60ML+PLAST

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: KARBOPLATINA

Notice details →
Czechia

ECUGRA 90MG TBL FLM 56 I

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: TIKAGRELOR

Notice details →
Czechia

FURORESE 125MG TBL NOB 100

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

FURORESE 125MG TBL NOB 30

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

FURORESE 125MG TBL NOB 50

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

FURORESE 250MG TBL NOB 20

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

FURORESE 250MG TBL NOB 50

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

FURORESE 40MG TBL NOB 50

Marketing resumed · Not specified
Active ingredient: FUROSEMID

Notice details →
Czechia

HYPABLO 100MG TBL PRO 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: METOPROLOL

Notice details →
Czechia

HYRIMOZ 40MG INJ SOL ISP 2X0,4ML ISP

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ADALIMUMAB

Notice details →
Czechia

HYRIMOZ 80MG INJ SOL PEP 1X0,8ML PEP

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ADALIMUMAB

Notice details →
Czechia

MIRTAZAPIN SANDOZ 45MG TBL FLM 30

Marketing resumed · Not specified
Active ingredient: MIRTAZAPIN

Notice details →
Czechia

NIMOTOP S 30MG TBL FLM 100 I

Marketing ended · Převod registrace
Active ingredient: NIMODIPIN

Notice details →
Czechia

PELGRAZ 6MG INJ SOL ISP 1X0,6ML ISP

Marketing resumed · Not specified
Active ingredient: PEGFILGRASTIM

Notice details →
Czechia

PERINDOPRIL TOSILATE/AMLODIPIN TEVA B.V. 5MG/5MG TBL NOB 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PERINDOPRIL A AMLODIPIN

Notice details →
Czechia

PIOGLITAZON ACTAVIS 15MG TBL NOB 28 KAL

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PIOGLITAZON

Notice details →
Czechia

PIOGLITAZON ACTAVIS 30MG TBL NOB 98 KAL

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PIOGLITAZON

Notice details →